Recital 38, Regulation (EU) 2016/161

In forcesince 2 Oct 2015

The information referred to in Article 33(2) of this Regulation and the information on the status of a unique identifier should stay accessible to all parties required to verify the authenticity of medicinal products, as such information is necessary for the proper performing of those verifications.